Audited Financial Results of the Company for quarter and financial year ended March 31, 2026

Pat Growth 25pctResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.1%Reaction day

₹410.00

prior close

₹409.95

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%-3.5% vs market

Medical Equipment & Supplies peers, median of 12sector-2.1%-2.0% vs sector

On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 2.0 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.4

10m

+1.1

15m

+0.5

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.1-0.6-3.5-2.1-2.0

Next day

-5.1-1.7-3.4-4.3-0.8

-5.3-0.7-4.7-5.6+0.2

-6.1-0.4-5.7-4.5-1.6

-7.0+0.4-7.5-7.0+0.0

-6.1+0.4-6.5-6.6+0.5

-10.7+0.3-11.0-8.6-2.2

15d

-3.9+5.5-9.4-6.8+2.9

-8.8+4.6-13.4-8.0-0.8

-6.1+5.3-11.4-6.0-0.0

-6.8+11.6-18.4-4.4-2.4

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Prevest Denpro Limited reported standalone revenue of ₹7,166.42 lakhs for FY26, up 13.64% from ₹6,306.77 lakhs in FY25. Net profit grew 17.67% to ₹2,141.82 lakhs from ₹1,820.13 lakhs. EPS improved to ₹17.84 from ₹15.16. The company operates dental products business with 3 subsidiaries - Denvisio Biomed (India), Axiodent INC (US), and Prevest Denpro Gulf (UAE). Cash and cash equivalents stood at ₹7,264.97 lakhs with zero debt. Statutory auditors Mittal & Associates issued an unmodified (clean) opinion on both standalone and consolidated financials.

Likely market impact

Positive results with ~18% PAT growth and strong cash position signal financial health. The clean audit opinion removes key risk concerns for investors. No debt and robust cash reserves provide buffer against economic headwinds.